IN2015DN01560A - - Google Patents
Info
- Publication number
- IN2015DN01560A IN2015DN01560A IN1560DEN2015A IN2015DN01560A IN 2015DN01560 A IN2015DN01560 A IN 2015DN01560A IN 1560DEN2015 A IN1560DEN2015 A IN 1560DEN2015A IN 2015DN01560 A IN2015DN01560 A IN 2015DN01560A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/04—General characteristics of the apparatus implanted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1085—Bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/16—Male reproductive, genital organs
- A61M2210/166—Prostate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nanotechnology (AREA)
- Saccharide Compounds (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261696029P | 2012-08-31 | 2012-08-31 | |
PCT/US2013/057841 WO2014036556A2 (en) | 2012-08-31 | 2013-09-03 | Drug delivery systems and methods for treatment of prostate |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN01560A true IN2015DN01560A (en) | 2015-07-03 |
Family
ID=49162284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1560DEN2015 IN2015DN01560A (en) | 2012-08-31 | 2015-02-25 |
Country Status (14)
Country | Link |
---|---|
US (2) | US9636488B2 (en) |
EP (1) | EP2890386A2 (en) |
JP (1) | JP6309009B2 (en) |
KR (2) | KR102383496B1 (en) |
CN (2) | CN112516154A (en) |
AU (1) | AU2013308465B2 (en) |
BR (1) | BR112015004110A2 (en) |
CA (1) | CA2882575C (en) |
IL (1) | IL237300B (en) |
IN (1) | IN2015DN01560A (en) |
MX (1) | MX367070B (en) |
RU (1) | RU2678308C2 (en) |
SG (1) | SG11201501483XA (en) |
WO (1) | WO2014036556A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015003836A2 (en) | 2012-08-31 | 2017-07-04 | Taris Biomedical Llc | drug delivery systems and methods for bladder cancer treatment |
SG11201501483XA (en) | 2012-08-31 | 2015-03-30 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine |
WO2015026813A1 (en) | 2013-08-19 | 2015-02-26 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
MX2016011333A (en) * | 2014-03-06 | 2016-12-07 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine. |
EP3200801B1 (en) * | 2014-10-02 | 2024-04-24 | University of Maryland, Baltimore | Methods of treating pancreatic cancer |
RS64032B1 (en) | 2016-05-06 | 2023-04-28 | Taris Biomedical Llc | Method of treating lower tract urothelial cancer |
SG10201913998YA (en) * | 2017-07-25 | 2020-03-30 | Taris Biomedical Llc | Methods of treating tumor metastasis |
WO2019094517A1 (en) | 2017-11-08 | 2019-05-16 | Taris Biomedical Llc | Methods of treatment and maintenance therapy for bladder cancer using gemcitabine |
CN112839653A (en) | 2018-08-01 | 2021-05-25 | 塔里斯生物医药公司 | Methods of treating overactive bladder using trospium chloride |
US20220107320A1 (en) | 2019-02-15 | 2022-04-07 | Incelldx, Inc. | Assaying Bladder-Associated Samples, Identifying and Treating Bladder-Associated Neoplasia, and Kits for Use Therein |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6171298B1 (en) | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
US20040260272A1 (en) | 2002-10-22 | 2004-12-23 | Friedman Craig D. | Method and system for intravesicular delivery of therapeutic agents |
US8361490B2 (en) * | 2004-09-16 | 2013-01-29 | Theracoat Ltd. | Biocompatible drug delivery apparatus and methods |
DE102005020314A1 (en) * | 2005-05-02 | 2006-11-09 | Infineon Technologies Ag | Voltage supply arrangement for supplying electrical load e.g. mobile telephone, has voltage converter with input and output, and control circuit controlling two switches based on control signals, where one switch is coupled at output |
ES2400091T3 (en) | 2005-08-11 | 2013-04-05 | Massachusetts Institute Of Technology | Intravesical drug delivery device and method |
US20100137239A1 (en) | 2006-04-24 | 2010-06-03 | Gloucester Pharmaceuticals | Gemcitabine combination therapy |
EP1913962A1 (en) * | 2006-10-22 | 2008-04-23 | Ophir Perelson | Expandable medical device for the treatment and prevention of cardiovascular diseases |
CN101616671A (en) * | 2007-01-19 | 2009-12-30 | 卫材R&D管理有限公司 | Composition for treatment of pancreatic cancer |
CN101896221B (en) | 2007-12-11 | 2013-06-05 | 麻省理工学院 | Implantable drug delivery device and methods for treatment of the bladder and other body vestcles or lumens |
MX2010010635A (en) | 2008-04-04 | 2010-12-17 | Lipella Pharmaceuticals Inc | Treatment of bladder dysfunction using liposomal botulinum toxin. |
CA2946195A1 (en) * | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
KR101689786B1 (en) | 2008-08-09 | 2016-12-26 | 메사츄세츠 인스티튜트 어브 테크놀로지 | Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues |
CN102470237A (en) | 2009-06-26 | 2012-05-23 | 塔里斯生物医药公司 | Solid drug tablets for implantable drug delivery devices |
US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
PL2512581T3 (en) | 2009-12-17 | 2021-11-02 | Taris Biomedical Llc | Implantable device with intravesical tolerability |
WO2011089604A2 (en) | 2010-01-20 | 2011-07-28 | Theracoat Ltd | Material and method for treating internal cavities |
US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
HUE052160T2 (en) | 2010-08-05 | 2021-04-28 | Taris Biomedical Llc | Ureteral stent drug delivery device and kit |
US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
US8690840B2 (en) | 2010-10-06 | 2014-04-08 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
US8979797B2 (en) | 2010-12-16 | 2015-03-17 | Ams Research Corporation | High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics |
WO2012096985A1 (en) | 2011-01-10 | 2012-07-19 | Taris Biomedical, Inc. | Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding |
BR112013019410A2 (en) * | 2011-02-04 | 2019-09-24 | Taris Biomedical Inc | implantable device for controlled release of low solubility drug |
US20150005595A1 (en) | 2011-12-30 | 2015-01-01 | Kibur Medical, Inc. | Implantable devices and methods for evaluation of active agents |
WO2013170069A1 (en) | 2012-05-09 | 2013-11-14 | Massachusetts Institute Of Technology | Medicament, method, and drug delivery device for treatment of ovarian cancer |
SG11201501483XA (en) | 2012-08-31 | 2015-03-30 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine |
BR112015003836A2 (en) | 2012-08-31 | 2017-07-04 | Taris Biomedical Llc | drug delivery systems and methods for bladder cancer treatment |
EP2897616A1 (en) | 2012-09-18 | 2015-07-29 | TARIS Biomedical LLC | Drug delivery systems and methods for treatment of bladder voiding dysfunction!and other lower urinary tract disorders by using trospium |
CN105163794B (en) | 2013-03-15 | 2020-03-27 | 塔里斯生物医药公司 | Drug delivery device and method with drug permeable member |
KR102270363B1 (en) | 2013-03-15 | 2021-06-29 | 타리스 바이오메디컬 엘엘씨 | Drug delivery devices |
JP6431528B2 (en) | 2013-04-10 | 2018-11-28 | マサチューセッツ インスチテュート オブ テクノロジーMassachusetts Institute Of Technology | Local drug delivery device and method for cancer treatment |
WO2015026813A1 (en) | 2013-08-19 | 2015-02-26 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
MX2016011333A (en) | 2014-03-06 | 2016-12-07 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine. |
-
2013
- 2013-09-03 SG SG11201501483XA patent/SG11201501483XA/en unknown
- 2013-09-03 KR KR1020207029566A patent/KR102383496B1/en active IP Right Grant
- 2013-09-03 AU AU2013308465A patent/AU2013308465B2/en not_active Ceased
- 2013-09-03 MX MX2015002452A patent/MX367070B/en active IP Right Grant
- 2013-09-03 RU RU2015109298A patent/RU2678308C2/en active
- 2013-09-03 KR KR20157007350A patent/KR20150043508A/en active Application Filing
- 2013-09-03 CN CN202011468367.8A patent/CN112516154A/en active Pending
- 2013-09-03 WO PCT/US2013/057841 patent/WO2014036556A2/en active Application Filing
- 2013-09-03 BR BR112015004110A patent/BR112015004110A2/en not_active Application Discontinuation
- 2013-09-03 CA CA2882575A patent/CA2882575C/en active Active
- 2013-09-03 JP JP2015530139A patent/JP6309009B2/en not_active Expired - Fee Related
- 2013-09-03 CN CN201380044809.8A patent/CN104812395A/en active Pending
- 2013-09-03 EP EP13760226.4A patent/EP2890386A2/en active Pending
-
2015
- 2015-02-18 IL IL237300A patent/IL237300B/en active IP Right Grant
- 2015-02-23 US US14/628,874 patent/US9636488B2/en active Active
- 2015-02-25 IN IN1560DEN2015 patent/IN2015DN01560A/en unknown
-
2017
- 2017-03-29 US US15/473,437 patent/US10406335B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2882575C (en) | 2020-05-26 |
MX2015002452A (en) | 2015-06-05 |
JP2015528469A (en) | 2015-09-28 |
EP2890386A2 (en) | 2015-07-08 |
US20150165177A1 (en) | 2015-06-18 |
CN104812395A (en) | 2015-07-29 |
JP6309009B2 (en) | 2018-04-11 |
CN112516154A (en) | 2021-03-19 |
BR112015004110A2 (en) | 2017-07-04 |
US9636488B2 (en) | 2017-05-02 |
WO2014036556A2 (en) | 2014-03-06 |
WO2014036556A3 (en) | 2014-04-17 |
US20170203085A1 (en) | 2017-07-20 |
CA2882575A1 (en) | 2014-03-06 |
KR20150043508A (en) | 2015-04-22 |
SG11201501483XA (en) | 2015-03-30 |
MX367070B (en) | 2019-08-05 |
KR102383496B1 (en) | 2022-04-08 |
IL237300A0 (en) | 2015-04-30 |
AU2013308465A1 (en) | 2015-03-05 |
US10406335B2 (en) | 2019-09-10 |
IL237300B (en) | 2020-02-27 |
RU2678308C2 (en) | 2019-01-25 |
KR20200120774A (en) | 2020-10-21 |
AU2013308465B2 (en) | 2018-05-17 |
RU2015109298A (en) | 2016-10-20 |